Follow the people · Insider
Michael Skynner
Michael Skynner files insider transactions with the SEC as a chief scientific officer of Bicycle Therapeutics (BCYC). We hold 6 disclosed purchases and sales filed since 30 May 2019, 2 of them in the last 90 days.
- Files forBCYC
- Disclosed buys and sells6 in all, 2 in the last 90 days
- Last disclosure7 July 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 28 May 2019 — 15 July 2026Chief Scientific Officer · Bicycle Therapeutics (BCYC)41 Form 4 lines · source: SEC Form 4
Everything they disclosed
41 entries, newest first — one per disclosure report, one per Form 4 line- was granted 60,000 shares of Bicycle Therapeutics (a derivative holding)SEC Form 417 July 2026Employee Stock Option (right to buy) · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 1,859 shares of Bicycle TherapeuticsSEC Form 47 July 2026Ordinary Shares · traded 2 July 2026 · filed 7 July 2026
- ▼ sold on the open market 532 shares of Bicycle TherapeuticsSEC Form 47 July 2026Ordinary Shares · traded 6 July 2026 · filed 7 July 2026
- ▼ sold on the open market 1,879 shares of Bicycle TherapeuticsSEC Form 46 April 2026Ordinary Shares · traded 2 April 2026 · filed 6 April 2026
- ▼ sold on the open market 525 shares of Bicycle TherapeuticsSEC Form 46 April 2026Ordinary Shares · traded 6 April 2026 · filed 6 April 2026
- was granted 50,000 shares of Bicycle TherapeuticsSEC Form 46 January 2026Ordinary Shares · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 3,045 shares of Bicycle TherapeuticsSEC Form 46 January 2026Ordinary Shares · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 3,266 shares of Bicycle TherapeuticsSEC Form 46 January 2026Ordinary Shares · traded 5 January 2026 · filed 6 January 2026
- was granted 100,000 shares of Bicycle Therapeutics (a derivative holding)SEC Form 46 January 2026Employee Stock Option (right to buy) · traded 2 January 2026 · filed 6 January 2026
- was granted 100,000 shares of Bicycle Therapeutics (a derivative holding)SEC Form 46 January 2026Employee Stock Option (right to buy) · traded 2 January 2026 · filed 6 January 2026
- was granted 50,000 shares of Bicycle TherapeuticsSEC Form 46 January 2026Ordinary Shares · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 3,045 shares of Bicycle TherapeuticsSEC Form 46 January 2026Ordinary Shares · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 3,266 shares of Bicycle TherapeuticsSEC Form 46 January 2026Ordinary Shares · traded 5 January 2026 · filed 6 January 2026
- ▼ sold on the open market 824 shares of Bicycle TherapeuticsSEC Form 46 October 2025Ordinary Shares · traded 2 October 2025 · filed 6 October 2025
- ▼ sold on the open market 978 shares of Bicycle TherapeuticsSEC Form 46 October 2025Ordinary Shares · traded 3 October 2025 · filed 6 October 2025
- ▼ sold on the open market 825 shares of Bicycle TherapeuticsSEC Form 47 July 2025Ordinary Shares · traded 2 July 2025 · filed 7 July 2025
- ▼ sold on the open market 966 shares of Bicycle TherapeuticsSEC Form 47 July 2025Ordinary Shares · traded 3 July 2025 · filed 7 July 2025
- ▼ sold on the open market 814 shares of Bicycle TherapeuticsSEC Form 44 April 2025Ordinary Shares · traded 2 April 2025 · filed 4 April 2025
- ▼ sold on the open market 1,038 shares of Bicycle TherapeuticsSEC Form 44 April 2025Ordinary Shares · traded 3 April 2025 · filed 4 April 2025
- was granted 87,000 shares of Bicycle Therapeutics (a derivative holding)SEC Form 46 January 2025Employee Stock Option (right to buy) · traded 2 January 2025 · filed 6 January 2025
- was granted 35,000 shares of Bicycle TherapeuticsSEC Form 46 January 2025Ordinary Shares · traded 2 January 2025 · filed 6 January 2025
- ▼ sold on the open market 3,287 shares of Bicycle TherapeuticsSEC Form 46 January 2025Ordinary Shares · traded 2 January 2025 · filed 6 January 2025
- ▼ sold on the open market 936 shares of Bicycle TherapeuticsSEC Form 46 January 2025Ordinary Shares · traded 3 January 2025 · filed 6 January 2025
- ▼ sold on the open market 972 shares of Bicycle TherapeuticsSEC Form 44 October 2024Ordinary Shares · traded 3 October 2024 · filed 4 October 2024
- ▼ sold on the open market 967 shares of Bicycle TherapeuticsSEC Form 48 July 2024Ordinary Shares · traded 3 July 2024 · filed 8 July 2024
- ▼ sold on the open market 955 shares of Bicycle TherapeuticsSEC Form 45 April 2024Ordinary Shares · traded 3 April 2024 · filed 5 April 2024
- was granted 56,000 shares of Bicycle Therapeutics (a derivative holding)SEC Form 44 January 2024Employee Stock Option (right to buy) · traded 2 January 2024 · filed 4 January 2024
- was granted 28,000 shares of Bicycle TherapeuticsSEC Form 44 January 2024Ordinary Shares · traded 2 January 2024 · filed 4 January 2024
- ▼ sold on the open market 2,643 shares of Bicycle TherapeuticsSEC Form 44 January 2024Ordinary Shares · traded 3 January 2024 · filed 4 January 2024
- ▼ sold on the open market 442 shares of Bicycle TherapeuticsSEC Form 45 October 2023Ordinary Shares · traded 3 October 2023 · filed 5 October 2023
- ▼ sold on the open market 451 shares of Bicycle TherapeuticsSEC Form 46 July 2023Ordinary Shares · traded 3 July 2023 · filed 6 July 2023
- ▼ sold on the open market 447 shares of Bicycle TherapeuticsSEC Form 45 April 2023Ordinary Shares · traded 3 April 2023 · filed 5 April 2023
- was granted 35,000 shares of Bicycle Therapeutics (a derivative holding)SEC Form 45 January 2023Employee Stock Option (right to buy) · traded 3 January 2023 · filed 5 January 2023
- was granted 17,500 shares of Bicycle TherapeuticsSEC Form 45 January 2023Ordinary Shares · traded 3 January 2023 · filed 5 January 2023
- ▼ sold on the open market 1,801 shares of Bicycle TherapeuticsSEC Form 45 January 2023Ordinary Shares · traded 3 January 2023 · filed 5 January 2023
- was granted 30,000 shares of Bicycle Therapeutics (a derivative holding)SEC Form 45 January 2022Employee Stock Option (right to buy) · traded 3 January 2022 · filed 5 January 2022
- was granted 15,000 shares of Bicycle TherapeuticsSEC Form 45 January 2022Ordinary Shares · traded 3 January 2022 · filed 5 January 2022
- was granted 70,500 shares of Bicycle Therapeutics (a derivative holding)SEC Form 45 January 2021Employee Stock Option (right to buy) · traded 4 January 2021 · filed 5 January 2021
- was granted 183,895 shares of Bicycle Therapeutics (a derivative holding)SEC Form 427 April 2020Stock Option (Right to Buy) · traded 28 June 2019 · filed 27 April 2020
- was granted 60,000 shares of Bicycle Therapeutics (a derivative holding)SEC Form 46 January 2020Employee Stock Option (right to buy) · traded 2 January 2020 · filed 6 January 2020
- was granted 183,895 shares of Bicycle Therapeutics (a derivative holding)SEC Form 430 May 2019Stock Option (Right to Buy) · traded 28 May 2019 · filed 30 May 2019
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.